EN
登录

人工智能技术平台提供商In-House Health获得400万美元种子轮融资,推出人工智能调度平台以应对护士短缺危机

In-House Health Raises $4 Million Seed Round, Unveils AI-Powered Scheduling Platform to Combat Nurse Shortage Crisis

businesswire 等信源发布 2024-05-08 18:29

可切换为仅中文


DENVER--(BUSINESS WIRE)--Today, In-House Health is announcing the formal launch of its AI-driven scheduling and management platform for modern nursing teams. The company has recently raised $4 million in seed funding led by NEA and TMV, with participation from pre-seed investors Vine Ventures and Longevity Venture Partners, bringing total investment to-date to $5.4 million..

丹佛--(商业新闻短讯)--今天,内部健康部门宣布正式推出其人工智能驱动的现代护理团队调度和管理平台。该公司最近在NEA和TMV的领导下筹集了400万美元的种子资金,种子前投资者Vine Ventures和长寿风险合作伙伴参与了该项目,迄今为止总投资达到540万美元。。

In-House Health was co-founded in 2023 by two healthcare professionals and a technical leader: Ari Brenner, Sergey Vasilenko and Shachar Har Zvi. Brenner previously served as Co-Founder and COO of Stellar Health, a healthcare technology company that works with payors and health systems to manage their value-based activities, while Vasilenko was a former critical care nurse who later transitioned to EMR/clinical informatics.

内部健康于2023年由两名医疗保健专业人员和一名技术领导者共同创立:Ari Brenner,Sergey Vasilenko和Shachar Har Zvi。Brenner曾担任Stellar Health的联合创始人兼首席运营官,Stellar Health是一家医疗技术公司,与支付方和医疗系统合作,管理其基于价值的活动,而Vasilenko曾是重症监护护士,后来转为EMR/临床信息学。

Har Zvi joined from Google, where he was a Technical Lead. In-House Health was born from firsthand experiences with inefficiencies in hospital staff management and how they could be solved through technology..

哈尔·兹维(HarZvi)是从谷歌(Google)加入的,他是谷歌的技术领导者。内部健康源于医院员工管理效率低下的第一手经验,以及如何通过技术解决这些问题。。

Nurse team leaders spend more than 15 hours a week managing shift schedules, buried in repetitive drag-and-drop screens, or even pen, paper and whiteboards. Additionally, while many hospitals typically employ thousands of employees, they often operate as regional silos. As a result, they are faced with unpredictable demand and challenges managing their employees, while constantly playing catch-up in response to changing circumstances..

护士团队领导每周花15个多小时管理轮班时间表,埋头于重复的拖放屏幕,甚至是笔、纸和白板。此外,虽然许多医院通常雇用数千名员工,但它们通常是区域性的孤岛。因此,他们面临着不可预测的需求和管理员工的挑战,同时不断追赶以应对不断变化的环境。。

In-House Health addresses this challenge by working closely with hospitals and providers to streamline staffing workflows. In-House’s AI algorithm is trained on millions of patient records to identify patterns of bedside care and anticipate shift changes weeks earlier than is normally possible. As a result, the algorithm can shorten hours spent on scheduling by half or more and reduce labor costs by over 10% across-the-board, amid the growing crisis of workforce shortage and spiraling costs to deliver care..

内部卫生部门通过与医院和提供者密切合作来解决这一挑战,以简化人员配置工作流程。内部的人工智能算法在数百万患者记录上进行了训练,以识别床边护理模式,并比通常可能的更早几周预测轮班变化。因此,在劳动力短缺和护理成本不断上升的危机日益严重的情况下,该算法可以将调度时间缩短一半或更多,并将劳动力成本降低10%以上。。

“Saving manager time on scheduling is a huge win and relieves burnout among nursing leaders, but the real prize is improved staffing outcomes,” explained Brenner. “When hospitals fail to properly predict the future, it costs money in overtime pay and agency use. We can reduce both through precision staffing.”.

Brenner解释说:“节省管理人员的时间是一个巨大的胜利,可以缓解护理领导者的倦怠感,但真正的好处是改善了人员配置的结果。”。“当医院无法正确预测未来时,加班费和机构使用都会产生成本。我们可以通过精确的人员配置来减少。”。

James Kerridge, DNP, Associate Chief Nurse, Chicago VA Medical Center and Board Member with the Illinois Organization of Nurse Leaders, joined In-House’s Nursing Advisory Board more than a year ago to help shape its product and clinical strategy.

James Kerridge,DNP,芝加哥弗吉尼亚州医疗中心副总护士,伊利诺伊州护士领袖组织董事会成员,一年多前加入众议院护理咨询委员会,帮助制定其产品和临床战略。

“In-House’s platform makes it easy for hospitals to schedule adaptively. This unlocks control over schedule and flexibility that is now critical to keep nurses satisfied and reduce burnout associated with last-minute changes,” said Kerridge.

Kerridge说:“内部平台使医院可以轻松地自适应安排时间表。这解除了对时间表和灵活性的控制,这对于保持护士满意和减少与最后一刻变化相关的倦怠至关重要。”。

In-House has experienced quick adoption from hospital executives and bedside nurses alike. Its system currently delivers scheduling and clinical insights to the management of more than 800 nurses.

内部经历了医院管理人员和床边护士的迅速采用。其系统目前为800多名护士的管理提供时间表和临床见解。

“At NEA, across our current and historical portfolio, we have deep experience across healthcare staffing markets. While there have been prior attempts to disrupt this market, we believe In-House’s focus on cutting reliance on third-party agencies and offering real-time clinical demand prediction is unique,” said Blake Wu, Partner at NEA.

NEA合伙人布莱克·吴(Blake Wu)表示:“在NEA,在我们目前和历史的投资组合中,我们在医疗保健人员市场方面拥有丰富的经验。虽然之前曾有人试图破坏这一市场,但我们相信House专注于减少对第三方机构的依赖并提供实时临床需求预测是独一无二的。”。

“We view this as a prime opportunity to back a category-defining clinical workforce optimization company and are excited to watch In-House lead the way in modernizing hospital staffing.”.

“我们认为这是支持一家定义类别的临床人力资源优化公司的绝佳机会,并很高兴看到内部在医院人员配置现代化方面发挥领导作用。”。

“One of our central themes at TMV is to invest in businesses transforming the future of the healthcare workforce,” explained Soraya Darabi, Co-founder and General Partner at TMV. “The bar is very high for hospital systems to purchase outside technology. In-House Health is distinctive in that they are a win for the nurse experience as well as the hospital bottom line.”.

TMV联合创始人兼普通合伙人索拉亚·达拉比(Soraya Darabi)解释说:“我们在TMV的中心主题之一是投资于改变医疗保健劳动力未来的企业。”。“医院系统购买外部技术的门槛很高。内部健康的独特之处在于,它不仅是护士体验的胜利,也是医院底线的胜利。”。

About In-House Health

关于内部健康

In-House Health is an AI-powered tech platform for modern nursing teams. Today, nurse staffing and scheduling is a manual, time-consuming process that often ineffectively distributes an increasingly strained workforce. In-House uses predictive analytics and automatic scheduling tools to guide nurse leaders, improving team experience at the bedside, patient safety, and financial outcomes.

内部健康是现代护理团队的人工智能技术平台。今天,护士的人员配置和调度是一个手动的,耗时的过程,通常无法有效地分配日益紧张的劳动力。内部使用预测分析和自动调度工具来指导护士领导,改善床边团队经验,患者安全和财务成果。

www.inhouse.health..

www.inhouse.health。。

About NEA

关于NEA

New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With nearly $24 billion in cumulative committed capital since the firm's founding in 1977, NEA invests in technology and healthcare companies at all stages in a company's lifecycle, from seed stage through IPO.

New Enterprise Associates,Inc.(NEA)是一家全球风险投资公司,专注于帮助企业家在多个阶段、部门和地区建立转型型企业。自1977年成立以来,NEA拥有近240亿美元的累积承诺资本,在公司生命周期的各个阶段(从种子阶段到IPO)投资于技术和医疗保健公司。

The firm's long track record of successful investing includes more than 230 portfolio company IPOs and more than 390 mergers and acquisitions. www.nea.com..

该公司的长期成功投资记录包括230多家投资组合公司的首次公开募股和390多家并购。www.nea.com。。

About TMV

关于TMV

TMV is an early-stage venture firm investing in the world's leading entrepreneurs reshaping legacy industries through tech-enabled innovation. Founded in 2016, TMV empowers founders with the capital and go-to-market bench required to reach critical inflection points and scale. With partners on the ground in New York, Chicago, Miami and London, TMV offers a global alliance for the leaders of tomorrow.

TMV是一家早期风险投资公司,投资于世界领先的企业家,通过技术创新重塑传统产业。TMV成立于2016年,为创始人提供了达到关键拐点和规模所需的资本和上市平台。TMV与纽约、芝加哥、迈阿密和伦敦的合作伙伴一起,为未来的领导者提供了一个全球联盟。